Roivant Sciences Ltd
NASDAQ:ROIV

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
NASDAQ:ROIV
Watchlist
Price: 11.55 USD -1.95% Market Closed
Market Cap: 8.5B USD
Have any thoughts about
Roivant Sciences Ltd?
Write Note

Wall Street
Price Targets

ROIV Price Targets Summary
Roivant Sciences Ltd

Wall Street analysts forecast ROIV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ROIV is 17.4 USD with a low forecast of 12.63 USD and a high forecast of 23.1 USD.

Lowest
Price Target
12.63 USD
9% Upside
Average
Price Target
17.4 USD
51% Upside
Highest
Price Target
23.1 USD
100% Upside

ROIV Last Price Targets
Roivant Sciences Ltd

The latest public price target was made on Oct 21, 2024 by David Risinger from Leerink Partners , who expects ROIV stock to rise by 47% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David Risinger
Leerink Partners
17 USD
Upside 47%
1 week ago
Oct 21, 2024
Leerink Partners Reiterates Outperform Rating on Roivant Sciences (ROIV)
StreetInsider
Corinne Jenkins
Goldman Sachs
17 USD
Upside 47%
1 month ago
Sep 19, 2024
Goldman Sachs Reiterates Buy Rating on Roivant Sciences (ROIV)
StreetInsider
Chi Fong
Bank of America Securities
12.5 USD
Upside 8%
1 month ago
Sep 11, 2024
Roivant Sciences (ROIV) PT Raised to $12.50 at BofA Securities
StreetInsider
Allison Bratzel
Piper Sandler
20 USD
Upside 73%
5 months ago
May 31, 2024
Piper Sandler Reiterates Overweight Rating on Roivant Sciences (ROIV)
StreetInsider
Douglas Tsao
H.C. Wainwright
18 USD
Upside 56%
6 months ago
Apr 3, 2024
Roivant Sciences (ROIV) PT Raised to $18 at H.C. Wainwright, 'brepocitinib has blockbuster potential'
StreetInsider
Neena Bitritto-Garg
Deutsche Bank
15 USD
Upside 30%
6 months ago
Apr 3, 2024
Roivant Sciences price target raised to $15 from $14 at Deutsche Bank
TheFly
Corinne Jenkins
Goldman Sachs
18 USD
Upside 56%
6 months ago
Apr 2, 2024
Roivant Sciences (ROIV) PT Raised to $18 at Goldman Sachs
StreetInsider
Corinne Jenkins
Goldman Sachs
16 USD
Upside 39%
7 months ago
Mar 13, 2024
Roivant Sciences (ROIV) PT Raised to $16 at Goldman Sachs
StreetInsider
Show More Price Targets
Show Less Price Targets
David Risinger
Leerink Partners
Price Target 17 USD
Upside/Downside 47%
View Source
Corinne Jenkins
Goldman Sachs
Price Target 17 USD
Upside/Downside 47%
View Source
Chi Fong
Bank of America Securities
Price Target 12.5 USD
Upside/Downside 8%
View Source
Allison Bratzel
Piper Sandler
Price Target 20 USD
Upside/Downside 73%
View Source
Douglas Tsao
H.C. Wainwright
Price Target 18 USD
Upside/Downside 56%
View Source
Neena Bitritto-Garg
Deutsche Bank
Price Target 15 USD
Upside/Downside 30%
View Source
Corinne Jenkins
Goldman Sachs
Price Target 18 USD
Upside/Downside 56%
View Source
Corinne Jenkins
Goldman Sachs
Price Target 16 USD
Upside/Downside 39%
View Source
Show More Price Targets
Show Less Price Targets
Roivant Sciences Ltd Competitors:
Price Targets
KOTRA
Kotra Industries Bhd
93% Downside
000513
Livzon Pharmaceutical Group Inc
14% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
3% Upside
4503
Astellas Pharma Inc
10% Upside
UCB
Ucb SA
4% Downside
002001
Zhejiang Nhu Co Ltd
5% Upside
CTLT
Catalent Inc
6% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Roivant Sciences Ltd

For the last 3 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 74%. The projected CAGR for the next 3 years is 53%.

74%
Past Growth
53%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ROIV's stock price target?
Price Target
17.4 USD

According to Wall Street analysts, the average 1-year price target for ROIV is 17.4 USD with a low forecast of 12.63 USD and a high forecast of 23.1 USD.

What is Roivant Sciences Ltd's Revenue forecast?
Projected CAGR
53%

For the last 3 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 74%. The projected CAGR for the next 3 years is 53%.

Back to Top